Ad is loading...
CSCJX
Price
$16.04
Change
-$0.16 (-0.99%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

CSCJX vs VISVX

Header iconCSCJX vs VISVX Comparison
Open Charts CSCJX vs VISVXBanner chart's image
CornerCap Small-Cap Value Institutional
Price$16.04
Change-$0.16 (-0.99%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
CSCJX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSCJX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSCJX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. CSCJX (136M). VISVX pays higher dividends than CSCJX: VISVX (1.90) vs CSCJX (1.07). CSCJX was incepted earlier than VISVX: CSCJX (9 years) vs VISVX (27 years). CSCJX is a more actively managed with annual turnover of: 131.00 vs. VISVX (16.00). CSCJX has a lower initial minimum investment than VISVX: CSCJX (2000) vs VISVX (3000). CSCJX (29.02) and VISVX (28.71) have marching annual gain over last year. VISVX return over 5 years is better than : 57.32 vs. CSCJX (16.37).
CSCJXVISVXCSCJX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years27 years-
Gain YTD13.35715.43387%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets136M57.6B0%
Annual Yield % from dividends1.071.9056%
Returns for 1 year29.0228.71101%
Returns for 3 years-19.6913.23-149%
Returns for 5 years16.3757.3229%
Returns for 10 yearsN/A108.21-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics